Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
This map shows the geographic impact of CDM Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CDM Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CDM Fletcher more than expected).
This network shows the impact of papers produced by CDM Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CDM Fletcher. The network helps show where CDM Fletcher may publish in the future.
Co-authorship network of co-authors of CDM Fletcher
This figure shows the co-authorship network connecting the top 25 collaborators of CDM Fletcher.
A scholar is included among the top collaborators of CDM Fletcher based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with CDM Fletcher. CDM Fletcher is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
16 of 16 papers shown
1.
Lg, Kindblom, et al.. (2010). WHO Clasification of Tumours of the Digestive System.10 indexed citations
2.
Fletcher, J., Maria Dêbiec‐Rychter, Bernadette Liegl, et al.. (2010). HSP90 inhibitor STA‐9090 potently suppresses secondary KIT kinase‐domain mutations responsible for gastrointestinal stromal tumor (GIST) progression during imatinib therapy.1 indexed citations
Fletcher, CDM, Eva van den Berg, & Willemina M. Molenaar. (2002). Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade sarcoma. University of Groningen research database (University of Groningen / Centre for Information Technology). 120–122.5 indexed citations
Tos, Angelo Paolo Dei, Claudio Doglioni, Roberta Maestro, et al.. (1999). Synovial sarcoma exhibits deregulation of the G1-S cell cycle checkpoint and of the apoptotic pathway. Laboratory Investigation. 79.3 indexed citations
8.
Somerhausen, Nicolas de Saint Aubain, Brian P. Rubin, & CDM Fletcher. (1999). Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differential diagnosis.. PubMed. 12(5). 463–71.115 indexed citations
9.
Tos, Angelo Paolo Dei, Catherine Wadden, Eduardo Calonje, et al.. (1995). Immunohistochemical demonstration of glycoprotein p30/32MIC2 (CD99) in synovial sarcoma. A potential cause of diagnostic confusion. 3(3). 168–173.39 indexed citations
Nascimento, Antonio G., Gary L. Keeney, & CDM Fletcher. (1994). Deciduoid peritoneal mesothelioma. An unusual phenotype affecting young females.. PubMed. 18(5). 439–45.64 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.